Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FB2001 in Hospitalized Patients With Moderate to Severe COVID-19
NCT05445934Phase 3Unknown
- Sponsor
- Frontier Biotechnologies Inc.
- Start
- Sep 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Compound 7b in coronavirus disease 2019 (COVID-19), sponsored by Frontier Biotechnologies Inc.. Status: unknown.
02
Drugs
Compound 7b
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05445934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05445934.